Delayed graft function has comparable associations with early outcomes in primary and repeat transplant among deceased-donor kidney transplant recipients.

Acute rejection DGF Donor characteristics Outcomes

Journal

Journal of nephrology
ISSN: 1724-6059
Titre abrégé: J Nephrol
Pays: Italy
ID NLM: 9012268

Informations de publication

Date de publication:
03 Oct 2024
Historique:
received: 11 07 2024
accepted: 01 09 2024
medline: 4 10 2024
pubmed: 4 10 2024
entrez: 3 10 2024
Statut: aheadofprint

Résumé

Delayed graft function (DGF) is a common complication and is associated with worse outcomes among kidney transplant recipients (KTRs). There are various risk factors for DGF including previous transplant. We hypothesized that DGF among KTRs undergoing repeat transplant has a greater impact on outcomes compared to primary KTRs. All deceased-donor KTRs between 01/2000 and 12/2020 at our center were included. Recipients were categorized as primary KTR or repeat KTR (any number of previous kidney transplants). Outcomes of interest included acute rejection, death-censored graft failure, and patient mortality within 12 months post-transplant. A total of 3137 deceased-donor KTRs were included; 2498(80%) were primary KTRs and 639(20%) were repeat KTRs. The rates of DGF were similar between the groups at 29% and 28%, respectively. Compared to KTRs without DGF, DGF was associated with a greater incidence of death and graft failure in both primary and repeat transplants; however, the risk of rejection was not significantly higher in repeat KTRs (p = 0.72). Comparing primary and repeat KTRs, there were no significant differences in either acute rejection (p-interaction = 0.11), death-censored graft failure (p-interaction = 0.38), or death (p-interaction = 0.37). In subgroup analysis among repeat KTRs with DGF, a repeat transplant with no prior DGF was associated with increased risk for death-censored graft failure and death but not for acute rejection. DGF in the prior transplant was protective against death-censored graft failure (HR: 0.07, 95% CI 0.005-0.98, p = 0.05) (p-interaction = 0.04), but this was not significantly associated with acute rejection or death. DGF is associated with similar detrimental outcomes among primary and repeat KTRs.

Sections du résumé

BACKGROUND BACKGROUND
Delayed graft function (DGF) is a common complication and is associated with worse outcomes among kidney transplant recipients (KTRs). There are various risk factors for DGF including previous transplant. We hypothesized that DGF among KTRs undergoing repeat transplant has a greater impact on outcomes compared to primary KTRs.
METHODS METHODS
All deceased-donor KTRs between 01/2000 and 12/2020 at our center were included. Recipients were categorized as primary KTR or repeat KTR (any number of previous kidney transplants). Outcomes of interest included acute rejection, death-censored graft failure, and patient mortality within 12 months post-transplant.
RESULTS RESULTS
A total of 3137 deceased-donor KTRs were included; 2498(80%) were primary KTRs and 639(20%) were repeat KTRs. The rates of DGF were similar between the groups at 29% and 28%, respectively. Compared to KTRs without DGF, DGF was associated with a greater incidence of death and graft failure in both primary and repeat transplants; however, the risk of rejection was not significantly higher in repeat KTRs (p = 0.72). Comparing primary and repeat KTRs, there were no significant differences in either acute rejection (p-interaction = 0.11), death-censored graft failure (p-interaction = 0.38), or death (p-interaction = 0.37). In subgroup analysis among repeat KTRs with DGF, a repeat transplant with no prior DGF was associated with increased risk for death-censored graft failure and death but not for acute rejection. DGF in the prior transplant was protective against death-censored graft failure (HR: 0.07, 95% CI 0.005-0.98, p = 0.05) (p-interaction = 0.04), but this was not significantly associated with acute rejection or death.
CONCLUSION CONCLUSIONS
DGF is associated with similar detrimental outcomes among primary and repeat KTRs.

Identifiants

pubmed: 39363124
doi: 10.1007/s40620-024-02104-5
pii: 10.1007/s40620-024-02104-5
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Informations de copyright

© 2024. The Author(s) under exclusive licence to Italian Society of Nephrology.

Références

Yarlagadda SG, Coca SG, Formica RN Jr, Poggio ED, Parikh CR (2009) Association between delayed graft function and allograft and patient survival: a systematic review and meta-analysis. Nephrol Dial transplant 24:1039–1047
doi: 10.1093/ndt/gfn667 pubmed: 19103734
Siedlecki A, Irish W, Brennan DC (2011) Delayed graft function in the kidney transplant. Am J Transplant Off J Am Soc Transplant Am Soc Transplant Surg 11:2279–2296
doi: 10.1111/j.1600-6143.2011.03754.x
Irish WD, Ilsley JN, Schnitzler MA, Feng S, Brennan DC (2010) A risk prediction model for delayed graft function in the current era of deceased donor renal transplantation. Am J Transplant Off J Am Soc Transplant Am Soc Transplant Surg 10:2279–2286
doi: 10.1111/j.1600-6143.2010.03179.x
Helantera I, Ibrahim HN, Lempinen M, Finne P (2020) Donor age, cold ischemia time, and delayed graft function. Clin J Am Soc Nephrol 15:813–821
doi: 10.2215/CJN.13711119 pubmed: 32404337 pmcid: 7274280
Ojo AO, Wolfe RA, Held PJ, Port FK, Schmouder RL (1997) Delayed graft function: risk factors and implications for renal allograft survival. Transplantation 63:968–974
doi: 10.1097/00007890-199704150-00011 pubmed: 9112349
Tapiawala SN, Tinckam KJ, Cardella CJ, Schiff J, Cattran DC, Cole EH et al (2010) Delayed graft function and the risk for death with a functioning graft. J Am Soc Nephrol 21:153–161
doi: 10.1681/ASN.2009040412 pubmed: 19875806 pmcid: 2799285
Fiorentino M, Gallo P, Giliberti M, Colucci V, Schena A, Stallone G et al (2020) Management of patients with a failed kidney transplant: what should we do? Clin Kidney J 14:98–106
doi: 10.1093/ckj/sfaa094 pubmed: 33564409 pmcid: 7857798
Lentine KL, Smith JM, Miller JM, Bradbrook K, Larkin L, Weiss S et al (2023) OPTN/SRTR 2021 annual data report: kidney. Am J Transplant Off J Am Soc Transplant Am Soc Transplant Surg 23:S21-s120
doi: 10.1016/j.ajt.2023.02.004
Ehrsam J, Rössler F, Horisberger K, Hübel K, Nilsson J, de Rougemont O (2022) Kidney retransplantation after graft failure: variables influencing long-term survival. Journal of transplantation 2022:3397751
doi: 10.1155/2022/3397751 pubmed: 35782455 pmcid: 9242806
Redfield RR, Scalea JR, Zens TJ, Muth B, Kaufman DB, Djamali A et al (2016) Predictors and outcomes of delayed graft function after living-donor kidney transplantation. Transpl Int 29:81–87
doi: 10.1111/tri.12696 pubmed: 26432507
Parajuli S, Joachim E, Alagusundaramoorthy S, Blazel J, Aziz F, Garg N et al (2019) Subclinical antibody-mediated rejection after kidney transplantation: treatment outcomes. Transplantation 103:1722–1729
doi: 10.1097/TP.0000000000002566 pubmed: 30507740
Parajuli S, Mandelbrot DA, Muth B, Mohamed M, Garg N, Aziz F et al (2017) Rituximab and monitoring strategies for late antibody-mediated rejection after kidney transplantation. Transplant Direct 3:e227
doi: 10.1097/TXD.0000000000000746 pubmed: 29536028 pmcid: 5828696
Parajuli S, Aziz F, Garg N, Panzer SE, Joachim E, Muth B et al (2019) Histopathological characteristics and causes of kidney graft failure in the current era of immunosuppression. World J Transplant 9:123–133
doi: 10.5500/wjt.v9.i6.123 pubmed: 31750089 pmcid: 6851501
Muth BL, Astor BC, Turk J, Mohamed M, Parajuli S, Kaufman DB et al (2016) Outpatient management of delayed graft function is associated with reduced length of stay without an increase in adverse events. Am J Transplant 16:1604–1611
doi: 10.1111/ajt.13689 pubmed: 26700736
Alshaikh EA, Astor BC, Muth B, Jorgenson M, Swanson K, Garg N et al (2023) Delayed Graft function among kidney transplant recipients is associated with an increased risk of urinary tract infection and BK viremia. Transplantation direct 9:e1526
doi: 10.1097/TXD.0000000000001526 pubmed: 37654682 pmcid: 10466499
Redfield RR, Gupta M, Rodriguez E, Wood A, Abt PL, Levine MH (2015) Graft and patient survival outcomes of a third kidney transplant. Transplantation 99:416–423
doi: 10.1097/TP.0000000000000332 pubmed: 25121473 pmcid: 4319995
Pour-Reza-Gholi F, Nafar M, Saeedinia A, Farrokhi F, Firouzan A, Simforoosh N et al (2005) Kidney retransplantation in comparison with first kidney transplantation. Transpl Proc 37:2962–2964
doi: 10.1016/j.transproceed.2005.08.034
Swanson KJ, Zhong W, Mandelbrot DA, Parajuli S (2024) Histopathological features and role of allograft kidney biopsy among recipients with prolonged delayed graft function: a review. Transplantation 108:1911–1921
doi: 10.1097/TP.0000000000004928 pubmed: 38383958

Auteurs

David Stoy (D)

Division of Nephrology, Department of Medicine, University of Wisconsin School of Medicine and Public Health, 1685 Highland Ave, Madison, WI, 4175 MFCB53705, USA.

Brenda Muth (B)

Division of Nephrology, Department of Medicine, University of Wisconsin School of Medicine and Public Health, 1685 Highland Ave, Madison, WI, 4175 MFCB53705, USA.

Brad C Astor (BC)

Division of Nephrology, Department of Medicine, University of Wisconsin School of Medicine and Public Health, 1685 Highland Ave, Madison, WI, 4175 MFCB53705, USA.
Department of Population Health Sciences, University of Wisconsin School of Medicine and Public Health, Madison, WI, USA.

Didier Mandelbrot (D)

Division of Nephrology, Department of Medicine, University of Wisconsin School of Medicine and Public Health, 1685 Highland Ave, Madison, WI, 4175 MFCB53705, USA.

Sandesh Parajuli (S)

Division of Nephrology, Department of Medicine, University of Wisconsin School of Medicine and Public Health, 1685 Highland Ave, Madison, WI, 4175 MFCB53705, USA. sparajuli@medicine.wisc.edu.

Classifications MeSH